[
  {
    "pmid": "12345678",
    "title": "Efficacy and Safety of Metformin in Type 2 Diabetes",
    "abstract": "Metformin is the first-line medication for type 2 diabetes. This meta-analysis of 100 studies shows that metformin effectively reduces HbA1c levels by 1-2% and has cardiovascular benefits. Common side effects include gastrointestinal disturbances in 20-30% of patients, which usually resolve with continued use.",
    "authors": "Smith J, Johnson A, Williams B",
    "journal": "Diabetes Care",
    "year": 2022,
    "keywords": [
      "Metformin",
      "Type 2 Diabetes",
      "HbA1c",
      "Cardiovascular"
    ]
  },
  {
    "pmid": "23456789",
    "title": "Antibiotic Treatment Guidelines for Acute Bacterial Sinusitis",
    "abstract": "Current guidelines recommend amoxicillin as first-line therapy for acute bacterial sinusitis in adults. Treatment duration should be 5-7 days for uncomplicated cases. Doxycycline or respiratory fluoroquinolones are alternatives for penicillin-allergic patients.",
    "authors": "Brown C, Davis E, Miller F",
    "journal": "Clinical Infectious Diseases",
    "year": 2023,
    "keywords": [
      "Sinusitis",
      "Antibiotics",
      "Amoxicillin",
      "Treatment Guidelines"
    ]
  },
  {
    "pmid": "34567890",
    "title": "Mechanisms of Metformin Action Beyond Glucose Lowering",
    "abstract": "Recent research reveals that metformin has pleiotropic effects beyond glycemic control, including anti-inflammatory properties, potential anti-cancer effects, and cardiovascular protection through AMPK activation and modulation of gut microbiota.",
    "authors": "Garcia H, Martinez I, Lopez J",
    "journal": "Nature Medicine",
    "year": 2023,
    "keywords": [
      "Metformin",
      "AMPK",
      "Mechanism",
      "Inflammation"
    ]
  }
]